Access to covid-19 vaccines : inequality between developed and developing countries

الملخص EN

In this article we discuss the concept of inequality access to COVID-19 vaccine between developed and developing countries.

Based on statistics on vaccination launches, countries which already have a pharmaceutical industry achieve better vaccination rates.

This pandemic has once again revealed the inequalities that exist in terms of unequal access to healthcare, drugs, and vaccines.

We offer a framework for understanding inequality in access to COVID-19 vaccines.

Decision-makers, especially in the South, must be aware of these challenges and strategize solutions that can be implemented at scale.

These include challenges around affordability, availability, and vaccination hesitancy.